Kunxinning Granules | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Medicine type
Traditional Chinese medicine
Therapeutic area
Urology & reproductive health
Indications recorded in the public source
TCM actions: warms yang, nourishes yin, supports the kidney and calms the liver. For female menopausal syndrome with the TCM pattern of dual kidney-yin and kidney-yang deficiency, presenting with hot flushes and sweating, cold pain in the lower back, alternating heat and chills, irritability or excitability, aversion to cold with cold limbs, vaginal dryness, low mood, dizziness, tinnitus, and insomnia with excessive dreaming; a pale tongue with a thin white coating and a deep, thready pulse.
Indication source and scope
Source date(s): 2024. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label. Additional indications may be supported by newer announcements or submissions rather than the older full label; see the indication sources.
Prescribing-information limitations
Indications checked against an official public submission. The full original prescribing information is still unavailable.
China availability status
Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status
Market-by-market verification pending.
Insurance classification
Included in national insurance (Category B)
Insurance edition
2025 edition; effective 1 January 2026
Insurance restrictions
No additional restriction is specified for this list entry; the list's general rules and approved indications still apply.
Insurance period
2025-01-01 to 2026-12-31
Insurance verification notes
Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions